|
1
|
Sunayama J, Sato A, Matsuda K, Tachibana
K, Watanabe E, Seino S, Suzuki K, Narita Y, Shibui S, Sakurada K,
et al: FoxO3a functions as a key integrator of cellular signals
that control glioblastoma stem-like cell differentiation and
tumorigenicity. Stem Cells. 29:1327–1337. 2011.PubMed/NCBI
|
|
2
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: Effects of radiotherapy with concomitant and
adjuvant temozolomide versus radiotherapy alone on survival in
glioblastoma in a randomised phase III study: 5-year analysis of
the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lathia JD, Mack SC, Mulkearns-Hubert EE,
Valentim CL and Rich JN: Cancer stem cells in glioblastoma. Genes
Dev. 29:1203–1217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stopschinski BE, Beier CP and Beier D:
Glioblastoma cancer stem cells-from concept to clinical
application. Cancer Lett. 338:32–40. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hardee ME, Marciscano AE, Medina-Ramirez
CM, Zagzag D, Narayana A, Lonning SM and Barcellos-Hoff MH:
Resistance of glioblastoma-initiating cells to radiation mediated
by the tumor microenvironment can be abolished by inhibiting
transforming growth factor-β. Cancer Res. 72:4119–4129. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu G, Yuan X, Zeng Z, Tunici P, Ng H,
Abdulkadir IR, Lu L, Irvin D, Black KL and Yu JS: Analysis of gene
expression and chemoresistance of CD133+ cancer stem cells in
glioblastoma. Mol Cancer. 5:672006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee J, Kotliarova S, Kotliarov Y, Li A, Su
Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, et al:
Tumor stem cells derived from glioblastomas cultured in bFGF and
EGF more closely mirror the phenotype and genotype of primary
tumors than do serum-cultured cell lines. Cancer Cell. 9:391–403.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mahesparan R, Read TA, Lund-Johansen M,
Skaftnesmo KO, Bjerkvig R and Engebraaten O: Expression of
extracellular matrix components in a highly infiltrative in vivo
glioma model. Acta neuropathol. 105:49–57. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie Y, Bergstrom T, Jiang Y, Johansson P,
Marinescu VD, Lindberg N, Segerman A, Wicher G, Niklasson M,
Baskaran S, et al: The human glioblastoma cell culture resource:
Validated cell models representing all molecular subtypes.
EBioMedicine. 2:1351–1363. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nusse R and Clevers H: Wnt/β-catenin
signaling, disease, and emerging therapeutic modalities. Cell.
169:985–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singh VK, Kumar N, Kalsan M, Saini A and
Chandra R: Mechanism of induction: Induced pluripotent stem cells
(iPSCs). J Stem Cells. 10:43–62. 2015.PubMed/NCBI
|
|
14
|
Takeda Y, Harada Y, Yoshikawa T and Dai P:
Chemical compound-based direct reprogramming for future clinical
applications. Biosci Rep. 38(pii): BSR201716502018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim SS, Pirollo KF and Chang EH: Isolation
and culturing of glioma cancer stem cells. Curr Protoc Cell Biol.
67:1–23. 2015. View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bi Y, Li H, Yi D, Bai Y, Zhong S, Liu Q,
Chen Y and Zhao G: β-catenin contributes to cordycepin-induced MGMT
inhibition and reduction of temozolomide resistance in glioma cells
by increasing intracellular reactive oxygen species. Cancer Lett.
435:66–79. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng T, Zhai K, Chang Y, Yao G, He J,
Wang F, Kong H, Xin H, Wang H, Jin M, et al: CHIR99021 combined
with retinoic acid promotes the differentiation of primordial germ
cells from human embryonic stem cells. Oncotarget. 8:7814–7826.
2017.PubMed/NCBI
|
|
19
|
Petkov S, Hyttel P and Niemann H: The
small molecule inhibitors PD0325091 and CHIR99021 reduce expression
of pluripotency-related genes in putative porcine induced
pluripotent stem cells. Cell Reprogram. 16:235–240. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peng X, Gao H, Wang Y, Yang B, Liu T, Sun
Y, Jin H, Jiang L, Li L, Wu M and Qian Q: Conversion of rat
embryonic stem cells into neural precursors in chemical-defined
medium. Biochem Biophys Res Commun. 431:783–787. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fan X, Xiong H, Wei J, Gao X, Feng Y, Liu
X, Zhang G, He QY, Xu J and Liu L: Cytoplasmic hnRNPK interacts
with GSK3β and is essential for the osteoclast differentiation. Sci
Rep. 5:177322015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang
Y, Deng J, Margolick JB, Liotta LA, Petricoin E III and Zhang Y:
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer
stem-like cells is required for viability and maintenance. Proc
Natl Acad Sci USA. 104:16158–16163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yuan J, Zhang F and Niu R: Multiple
regulation pathways and pivotal biological functions of STAT3 in
cancer. Sci Rep. 5:176632015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kucuksayan HH and Akgun SS: Pl3K/Akt/NF-κB
Signalling Pathway on NSCLC Invasion. Med Chem. 6:234–238. 2016.
View Article : Google Scholar
|
|
25
|
Matsuoka T and Yashiro M: The Role of
PI3K/Akt/mTOR signaling in gastric carcinoma. Cancers. 6:1441–1463.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Happold C, Roth P, Silginer M, Florea AM,
Lamszus K, Frei K, Deenen R, Reifenberger G and Weller M:
Interferon-β induces loss of spherogenicity and overcomes therapy
resistance of glioblastoma stem cells. Mol Cancer Ther. 13:948–961.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qiu ZK, Shen D, Chen YS, Yang QY, Guo CC,
Feng BH and Chen ZP: Enhanced MGMT expression contributes to
temozolomide resistance in glioma stem-like cells. Chin J Cancer.
33:115–122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lai IC, Shih PH, Yao CJ, Yeh CT, Wang-Peng
J, Lui TN, Chuang SE, Hu TS, Lai TY and Lai GM: Elimination of
cancer stem-like cells and potentiation of temozolomide sensitivity
by Honokiol in glioblastoma multiforme cells. PLoS One.
10:e01148302015. View Article : Google Scholar : PubMed/NCBI
|
